Biopharmaceutical company Moderna will be added to the Nasdaq today, with high-profit accounts expecting the stock price to rise another 70%.

BlockBeats news, October 9: Moderna will officially be added to the Nasdaq 100 Index before the U.S. stock market opens at 21:30 Beijing time tonight (October 9), replacing Warner Bros. Discovery. The adjustment was announced on October 1.

From the close of U.S. stocks on October 1 before the announcement to the latest close on October 8, MRNA's stock price rose from $188.94 to $197, accumulating a gain of about 4.27%.

Moderna is an American biotechnology company that develops vaccines and drugs using mRNA technology, with research covering infectious diseases, cancer, and rare diseases. In addition to its vaccine business, the company's personalized mRNA cancer therapy in collaboration with Merck announced positive Phase 3 trial results in August, meeting the primary endpoint of recurrence-free survival in adjuvant treatment of melanoma, serving as the main catalyst for the stock price.

Recently, a suspected pneumonic plague incident in Russia also drew attention to vaccine stocks, with Moderna rising about 6.95% on October 5. However, as of the latest public information, the pathogen in the incident has not been confirmed by the WHO; Russia said testing of contacts found no plague; the European Centre for Disease Prevention and Control also stated that there is no evidence of sustained human-to-human transmission.

According to TradingBeats monitoring, MRNA on-chain contracts are quoted at $196.45, up about 0.56% in 24 hours; open interest is about 15,600 contracts, with a notional value of about $3.059 million; 24-hour trading volume is about 43,500 contracts, with a turnover of about $8.521 million.

The two largest longs together hold about $448,500 in long positions, with unrealized profit of about $61,500:

- Largest long: about $242,500 in long positions. Holds 1,233.05 contracts with 3x leverage, average price $175.78, unrealized profit about $25,800, return about 35.7%, liquidation price $124.15 (0x9a37…).

- Second-largest long: about $205,900 in long positions. Holds 1,046.98 contracts with 10x leverage, average price $162.58, unrealized profit about $35,700, return about 209.8%, liquidation price $154.69 (0x599d…).

The second-largest long has set a market take-profit trigger order at $350 covering all existing positions, about 77.9% above the current price.